Skip to main content Accessibility help
×
Home

Vestibular schwannoma: role of conservative management

  • R Suryanarayanan (a1), R T Ramsden (a1), S R Saeed (a2), R Aggarwal (a1), A T King (a3), S A Rutherford (a3), D G Evans (a4) and J E Gillespie (a5)...

Abstract

Objective:

To assess the outcome of conservative management of vestibular schwannoma.

Study design:

Observational study.

Setting:

Tertiary referral centre.

Patients:

Four hundred and thirty-six patients with vestibular schwannoma (490 tumours), including 327 sporadic tumours and 163 tumours in 109 patients with neurofibromatosis type two.

Main outcome measures:

The relationship of tumour growth to tumour size at presentation, and to certain demographic features.

Results:

The initial tumour size was significantly larger in the neurofibromatosis type two group (11 mm) than in the sporadic vestibular schwannoma group (5.1 mm). In both groups, 68 per cent of tumours did not grow during follow up (mean 3.6 years; range one to 14 years). The mean growth rate was 1.1 mm/year (range 0–15 mm/year) for sporadic tumours and 1.7 mm/year (range 0–18 mm/year) for neurofibromatosis type two tumours. The tumour growth rate correlated positively with tumour size in the sporadic tumour group, and correlated negatively with age in the neurofibromatosis type two group.

Conclusion:

Two-thirds of vestibular schwannomas did not grow. Radiological surveillance is an acceptable approach in carefully selected patients. Once a sporadic vestibular schwannoma reaches 2 cm in intracranial diameter, it is likely to continue growing. We do not recommend conservative management for sporadic tumours with an intracranial diameter of 1.5 cm or more. Vestibular schwannoma management is more complex in patients with neurofibromatosis type two.

Copyright

Corresponding author

Address for correspondence: Mr R Suryanarayanan, 56 California Close, Warrington WA5 8WU, UK. Fax: 01925 415280 E-mail: drsury@gmail.com

References

Hide All
1Kanzaki, J, Tos, M, Sanna, M. New and modified reporting systems from the consensus meeting on systems for reporting results in Vestibular Schwannoma. Otol Neurotol 2003;24:642–9
2Nikolopoulos, TP, O'Donoghue, GM. Acoustic neuroma management: an evidence-based medicine approach. Otol Neurotol 2002;23:534–41
3Yoshimoto, Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005;103:5963
4Suryanarayanan, R, Lesser, THJ. Growth rate of vestibular schwannoma – what the literature tells us. The Otorhinolaryngologist 2007;1:6671
5Selesnick, HS, Johnson, G. Radiologic surveillance of acoustic neuromas. Am J Otol 1998;19:846–9
6Smouha, EE, Yoo, M, Mohr, K, Davis, RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 2005;115:450–4
7Yamakami, I, Uchino, Y, Kobayashi, E, Yamaura, A. Conservative management, gamma-knife radiosurgery and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 2003;25:682–90
8Baser, ME, Mautner, VF, Parry, DM, Evans, DGR. Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet 2005;42:903–6
9Ogawa, K, Kanzaki, J, Ogawa, S, Yamamoto, M, Ikeda, S, Shiobara, R. The growth rate of acoustic neuromas. Acta Otolaryngol Suppl 1991;487:157–63
10Charabi, S, Thomsen, J, Tos, M, Charabi, B, Mantoni, M, Borgesen, SE. Acoustic neuroma/vestibular schwannoma growth: past, present and future. Acta Otolaryngol 1998;118:327–32
11Niemczyk, K, Vaneecloo, FM, Lemaitre, L, Lejeune, JP, Skarzynski, H, Dubrulle, F. The growth of acoustic neuromas in volumetric radiologic assessment. Am J Otol 1999;20:244–8
12Laasonen, E, Troupp, H. Volume growth rate of acoustic neurinomas. Neuroradiology 1986;28:203–7
13Valvassori, GE, Guzman, M. Growth rate of acoustic neuromas. Am J Otol 1989;10:174–6
14Mirz, F, Jorgensen, B, Fiirgaard, B, Lundorf, E, Pedersen, CB. Investigations into the natural history of vestibular schwannomas. Clin Otol 1999;24:1318
15Fucci, MJ, Buchman, CA, Brackmann, DE, Berliner, KI. Acoustic tumour growth: implications for treatment choices. Am J Otol 1999;20:495–9
16Martin, TPC, Tzifa, K, Kowalski, C, Holder, RL, Walsh, R, Irving, RM. Conservative versus primary surgical treatment of acoustic neuromas: a comparison of rates of facial nerve and hearing preservation. Clin Otolaryngol 2008;33:228–35
17Walsh, RM, Bath, AP, Bance, ML, Keller, A, Tator, CH, Rutka, JA. The role of conservative management of vestibular schwannomas. Clin Otolaryngol 2000;25:2839
18Charabi, S, Thomsen, J, Mantoni, M, Charabi, B, Jorgensen, B, Borgesen, SE. Acoustic neuroma: growth and surgical and nonsurgical consequences of the wait and see policy. Otolaryngol Head Neck Surg 1995;113:514
19Tschudi, DC, Linder, TE, Fisch, U. Conservative management of unilateral acoustic neuromas. Am J Otol 2000;21:722–8
20Deen, HG, Ebersold, MJ, Harner, SG, Beatty, CW, Marion, MS, Wharen, RE. Conservative management of acoustic neuroma: an outcome study. Neurosurgery 1996;39:260–4
21O'Reilly, B, Murray, CD, Hadley, DM. The conservative management of acoustic neuroma: a review of forty-four patients with magnetic resonance imaging. Clin Otolaryngol 2000;25:93–7
22Herwadker, A, Vokurka, EA, Evans, DGR, Ramsden, RT, Jackson, A. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation. Otol Neurotol 2005;26:8692
23Mohyuddin, A, Vokurka, EA, Evans, DG, Ramsden, RT, Jackson, A. Is clinical growth index a reliable predictor of tumor growth in vestibular schwannomas? Clin Otolaryngol 2003;28:8590
24Rosenberg, SI. Natural history of acoustic neuromas. Laryngoscope 2000;110:497508
25Evans, DG, Trueman, L, Wallace, A, Collins, S, Strachan, T. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998;35:450–5
26Baser, ME, Kuramoto, L, Joe, H, Friedman, JM, Wallace, AJ, Gillespie, JE et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet 2004;75:231–9

Keywords

Vestibular schwannoma: role of conservative management

  • R Suryanarayanan (a1), R T Ramsden (a1), S R Saeed (a2), R Aggarwal (a1), A T King (a3), S A Rutherford (a3), D G Evans (a4) and J E Gillespie (a5)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed